Yang Q, Wang B, Gao W, Huang S, Liu Z, Li W, et al
Statistical analyses were conducted using SPSS Version 29.0 (SPSS Inc., Chicago, IL, USA)
Kamei, J., Mizoguchi, H., Narita, M
Whether the conclusions drawn for licensed GLP-1 receptor agonists will extend to retatrutide a structurally distinct triple agonist with additional glucagon receptor activity remains to be determined through ongoing and future trials
Always consult your healthcare provider to discuss the risks and benefits of semaglutide for your specific health needs
They note that the findings are consistent with previous preclinical research, registry-based studies, and smaller clinical investigations suggesting that GLP-1 receptor agonists may influence alcohol-related behaviors